4.58
4.58 (0.03%)
As of Jan 14, 2022
Acurx Pharmaceuticals, Inc. [ACXP]
Source:
Company Overview
Acurx Pharmaceuticals, Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization (“WHO”), the U.S. Centers for Disease Control and Prevention (“CDC”) and the U.S. Food and Drug Administration (“FDA”).
Country | United States |
Headquarters | staten island, new york |
Phone Number | 917-533-1469 |
Industry | |
CEO | David P. Luci |
Website | www.acurxpharma.com |